Technically Speakin...
Health Care: Drugs
Cypress Biosciences Inc. (CYPB: NASDAQ)
$6.50 0.01 | 0.15%
01/13/11 - 04:00 PM ET
Ratio Comparisons
Financial Ratios data is not available for CYPB.
Portfolios with CYPB
- Portfolio NameUser Type
- Userbiotech
- ContributorBarron's Activist Stocks 7-...
- User©SUPRATRADE HOT STOCKS (...
- Userpkc89
- Usercool_Portfolio_16nov2009
- UserFCNBK
- Userstilskin Portfolio 1
- Userflabarb64 Portfolio 1
- UserIzone
- Usersoluonos Portfolio 1
Latest CYPB Headlines from TheStreet
- Layoffs Mount in 2010: What Does It Mean for 2011? 01.06.11 | 05:01 pm
- Worst Biotech CEO of 2010 Is... 12.09.10 | 07:12 am
- Harbor Bio, Cypress Bio: Volume Movers 09.15.10 | 08:09 am
- Jazz Pharma - FDA Panel Prep 08.03.10 | 04:08 am
- Buy AK Steel and Hold Cypress Bioscience
07.21.10 | 10:07 am - Buy Halliburton, Short Silver Wheaton 07.20.10 | 10:07 am
- Cypress Bioscience, Zagg: Volume Movers 07.19.10 | 08:07 am
- Navarro's High Volume Movers 06.22.10 | 10:06 am
- InfoLogix, RADA Electronic: Volume Movers 06.21.10 | 12:06 pm
- Cypress Bioscience Takes Bigger Loss As Costs Rise 11.09.09 | 02:11 pm
Press Releases for CYPB
- Cypress Bioscience, Inc. Shareholder Investigation By Briscoe Law Firm Concerning Acquisition By Ramius V&O Acquisition, LLC - Business Wire 12.20.10 | 12:12 pm
- The Law Office Of Abe Shainberg Launches An Investigation Into The Possible Breaches Of Fiduciary Duty By The Board Of Cypress Bioscience, Inc. In Connection With The Sale Of Company To Ramius V & O Acquisition, LLC– CYPB - Business Wire 12.17.10 | 01:12 pm
- The Law Firm Of Levi & Korsinsky, LLP Launches An Investigation Into The Possible Breaches Of Fiduciary Duty By The Board Of Cypress Bioscience, Inc. In Connection With The Sale Of Company To Ramius V & O Acquisition, LLC– CYPB - Business Wire 12.16.10 | 11:12 am
- The Law Firm Of Weiss & Lurie Investigates The Acquisition Of Cypress Bioscience, Inc. By Ramius V&O Acquisition LLC And Royalty Pharma - Business Wire 12.15.10 | 02:12 pm
- Cypress Bioscience Agrees To Be Acquired By Ramius LLC And Royalty Pharma For $6.50 Per Share In Cash - Business Wire 12.15.10 | 08:12 am
- Cypress Bioscience Board Of Directors Confirms Receipt Of Revised Ramius LLC Offer In Connection With Strategic Review Process - Business Wire 12.10.10 | 11:12 am
- Alexza's Staccato® Nicotine Licensed To Cypress Bioscience - PR Newswire 08.26.10 | 08:08 am
- Law Offices Of Howard G. Smith Announces Investigation On Behalf Of Shareholders Of Cypress Bioscience, Inc. - Business Wire 07.21.10 | 09:07 pm
- Kendall Law Group Investigates Cypress Bioscience, Inc. Acquisition For Shareholders - Business Wire 07.20.10 | 03:07 pm
- Rigrodsky & Long, P.A. Investigates Cypress Bioscience, Inc. Going Private Offer - Business Wire 07.20.10 | 11:07 am
Partner Headlines for CYPB
- Cypress Bio Bought by Ramius - Analyst Blog - Zacks 12.17.10 | 02:12 pm
- Stock Market News for Dec 16, 2010 - Market News - Zacks 12.16.10 | 10:12 am
- UPDATE 1-Cypress rebuffs sweetened offer from Ramius - Reuters 12.14.10 | 11:12 am
- Cypress Up on Revised Ramius Bid - Analyst Blog - Zacks 12.13.10 | 08:12 am
- Cypress Rises 20 Percent on the Possibility of a Sale to Ramius: Biotech's Latest M&A Action - Seeking Alpha 12.12.10 | 09:12 am
- UPDATE 1-Ramius sweetens bid for Cypress Bioscience for 2nd time - Reuters 12.10.10 | 10:12 am
- Cypress Bioscience (CYPB) - Bear of the Day - Zacks 11.29.10 | 01:11 am
- Wider Loss at Cypress Bio - Analyst Blog - Zacks 11.17.10 | 09:11 am
- Cypress Bio Sells Diagnostics Biz - Analyst Blog - Zacks 10.11.10 | 09:10 am
- UPDATE 1-Cypress Bioscience to sell diagnostic unit for $8 mln - Reuters 10.08.10 | 05:10 pm
